Blood-based tumor biomarkers in lung cancer for detection and treatment
Hirva Mamdani(Wayne State University), Shadia I. Jalal(Indiana University Health), Samantha Armstrong(Indiana University School of Medicine), Shahid Ahmed(Saskatchewan Health), Tony Mok(Chinese University of Hong Kong)
Cited by 75
Related Papers
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
|New England Journal of Medicine|2009|8.2k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k